The Orlando Medical Corporation financial statements follow. ::: (Click the icon to view the consolidated balance sheets.) Orlando Medical's current ratio at year-end 2018 is closest to O A. $735. O B. $8,578 OC. 0.94 OD. 1.2 1 Data Table 520 Orlando Medical Corporation Consolidated Statements of Financial Position December 31, (in Millions) 2018 2017 Assets: Current assets Cash and cash equivalents 4,333 $ 4.226 Short-term investments 845 Accounts and notes receivable 3,400 2.403 Inventories, at cost 411 Prepaid expense and other current assets 1.638 1,226 Total current assets 10.649 8,786 Property and equipment, net 1.555 907 Investments 6,804 5.199 Other non-current assets 303 155 $ 19,311 $ 15.047 Total assets Llabilities and stockholder's equity: Print Done Uula TUIC 7,708 $ 3,676 6,009 3,033 11,384 304 1,701 9,042 305 1,179 13,389 10,526 Liabilities and stockholder's equity: Current liabilities Accounts payable Accrued and other liabilities Total current liabilities Long-term debt Other non-current liabilities Total liabilities Stockholders' equity Preferred stock and capital in excess of $0.02 par value: shares issued and outstanding: none Common stock and capital in excess of $0.05 par value; shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost; 183 and 123 shares, respectively Retained earnings Other comprehensive loss Other 7.803 BE7,001 (6.444) (4.401) 4.676 1,990 (79) (25 (34) (44) 5,922 4,521 Total stockholderetanuit Print Done A Data Table 7,708 $ 3,676 6,009 3,033 9,042 11,384 304 1,701 305 1,179 13,389 10,526 UITERE M ERE Accounts payable Accrued and other liabilities Total current liabilities Long-term debt Other non-current liabilities Total liabilities Stockholders' equity Preferred stock and capital in excess of $0.02 par value; shares issued and outstanding: none Common stock and capital in excess of $0.05 par value; shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost; 183 and 123 shares, respectively Retained earnings Other comprehensive loss Other Total stockholders' equity 7,803 (6.444) 4,676 (79) (34) 5.922 19.311 7,001 (4.401) 1,990 (25) (44) 4,521 15.047 Total liabilities and stockholders' equity Print Done Data Table Orlando Medical Corporation Consolidated Statements of Income Year ended December 31, (in Millions, Except per Share Amounts) 2018 2017 2016 Net revenue 42,666 $ 35,220 $ 31,111 Cost of goods sold 35,147 29,255 25,492 7,519 5,965 5,619 Gross profit Operating expenses: Selling, general, and administrative 3,341 3,250 2,985 Research, development, and engineering 544 512 Special charges 3.885 3,803 4,033 Total operating expenses Operating income 3.634 2.162 1586 153 196 (30) Investment and other income (loss), net Income before income taxes 3,787 2.358 1556 1136 940 Income tax expense A2651 5 1418 5 1094 553 536 Print Done 1 Data Table U srcu ut us 2018 2017 42,666 S 35,220 $ 31,111 35,147 29,255 25,492 7.519 5,965 5,619 3,341 2,985 3,250 553 544 536 (In Millions, Except per Share Amounts) Net revenue Cost of goods sold Gross profit Operating expenses: Selling, general, and administrative Research, development, and engineering Special charges Total operating expenses Operating income Investment and other income (loss), net Income before income taxes Income tax expense Net income 512 4,033 3,885 3,803 3,634 153 2.162 196 1586 (30) 1556 3.787 1.136 2.358 940 2.651 S 1.418 S Eamings per common share: Basic Print Done